Company Search:
Advanced Search
Sponsored Links
Vifor Pharma AG Company Snapshot
Vifor Pharma AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vifor Pharma AG with three other pharmaceutical manufacturers in Europe: Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag of Hungary (2018 sales of 445.48 billion Hungarian Forints [US$1.49 billion] of which 80% was Pharmaceutical Manufacturing and Sale), Recordati SpA of Italy (1.35 billion Euro [US$1.50 billion] of which 84% was Specialty & Primary care), and Krka DD Novo Mesto which is based in Slovenia (1.33 billion Euro [US$1.47 billion] of which 60% was European Union).

Sales Analysis. During the year ended December of 2018, sales at Vifor Pharma AG were 1.58 billion Swiss Francs (US$1.60 billion). This is an increase of 18.1% versus 2017, when the company's sales were 1.34 billion Swiss Francs. Despite this increase, sales are still well below the level achieved in 2016, when Vifor Pharma AG reported sales of 4.12 billion Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vifor Pharma AG
  Stock Performance Chart for Vifor Pharma AG
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 158.15
(Figures in Swiss Francs)
1 Week -0.1%   13 Weeks 2.7%  
4 Weeks 14.1%   52 Weeks -10.1%  
Vifor Pharma AG Key Data:
  Ticker: VIFN Country: Switzerland
  Exchanges: GVA OTH ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,584,600,000
(Year Ending Jan 2019).
Employees: 2,700
  Currency: Swiss Francs Market Cap: 10,255,106,593
  Fiscal Yr Ends: December Shares Outstanding: 64,844,177
  Share Type: Namenaktie Closely Held Shares: 21,259,239
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.